0001562180-19-003969.txt : 20190717
0001562180-19-003969.hdr.sgml : 20190717
20190717160237
ACCESSION NUMBER: 0001562180-19-003969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190717
FILED AS OF DATE: 20190717
DATE AS OF CHANGE: 20190717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IGUCHI KIMI
CENTRAL INDEX KEY: 0001304815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 19959182
MAIL ADDRESS:
STREET 1: 100 FOXBOROUGH BOULEVARD
STREET 2: SUITE 240
CITY: FOXBOROUGH
STATE: MA
ZIP: 02035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-07-17
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001304815
IGUCHI KIMI
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
CFO & Treasurer
Common Stock
2019-07-17
4
M
false
4000.00
1.36
A
10409.00
D
Stock Option (Right to Buy)
1.36
2019-07-17
4
M
false
4000.00
0.00
D
2024-01-24
Common Stock
4000.00
8698.00
D
Reflects beneficial ownership balance which includes 273 ESPP shares purchased on June 30, 2019.
The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on January 1, 2018.
/s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi
2019-07-17